Injective (INJ) is currently trading at $4.01, a decline of 10.18% for the day, positioning it below the MA-20 at $4.89, MA-50 at $4.90, and well under the MA-200 at $9.44, highlighting sustained bearish pressure over multiple timeframes.
Highlights
- INJ trades at $4.01, well below MA-20 ($4.89), MA-50 ($4.90), and MA-200 ($9.44), underpinning a firmly bearish setup across all timeframes.
- Intraday momentum indicators (MACD, ADX, RSI 41.88, StochRSI 34.09, CCI –76.99) confirm persistent selling with price nearing, but not breaching, oversold territory.
- Key price levels are $3.83 support and $5.05 resistance, with a projected five-day range of $3.83–$4.45 and less than 20% rebound probability.
Seller dominance confirmed as all momentum signals align bearish
Momentum remains weak, with the daily MACD showing a sell bias and ADX indicating a lack of a strong trend. The RSI (41.88), Stochastic RSI (34.09), and CCI (–76.99) point to a market edging toward oversold, though not yet deeply so. BBP and the Awesome Oscillator both favor the bears, confirming that sellers are dominating intraday moves. The price dropped 10.18% today after opening nearly flat to the previous session's close, with current levels near the lower end of the day’s trading range, reflecting high volatility and sustained selling pressure after the open. All key intraday and momentum signals align on a bearish tone, with no material divergence among oscillators and trend indicators.
Previously it was reported that Injective is trading under persistent bearish pressure, remaining well below its major moving averages with downside momentum prevailing across key technical indicators such as the MACD and ADX. Sellers maintain control as no clear support is identified and volatility remains high, suggesting the asset is likely to consolidate or trend lower within its current range barring a significant technical shift.
Latest Injective News
- Forex
- Crypto